Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.

< BACK TO ARCHIVE


2022 Mar 22


Head Neck


http://www.ncbi.nlm.nih.gov/pubmed/35315549?dopt=Abstract

Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.

Authors

Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.
Gilley DR, Clark AD, Wieser ME, Bollig CA, Dooley LM, Biedermann GB
Head Neck. 2022 Mar 22.
PMID: 35315549.

Abstract

Gabapentin has been shown to reduce opioid use in head and neck cancer patients. Here, we examine the efficacy of prophylactic gabapentin at reducing opioid use in these patients at our institution.
Read This Paper